Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Diluted Shares Outstanding

Apellis Pharmaceuticals Inc Diluted Shares Outstanding Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Diluted Shares Outstanding from 2017 to 2018.
  • Apellis Pharmaceuticals Inc Diluted Shares Outstanding for the quarter ending December 12, 2018 was $56m a 10.52% increase of 6m year over year
  • Apellis Pharmaceuticals Inc Diluted Shares Outstanding for the last 12 months ending December 12, 2018 was $54m a 55.23% increase of 30m year over year
  • Apellis Pharmaceuticals Inc Annual Diluted Shares Outstanding for 2018 was $54m a 74.50% increase of 41m from 2017
  • Apellis Pharmaceuticals Inc Annual Diluted Shares Outstanding for 2017 was $14m a 39.24% increase of 5m from 2016
  • Apellis Pharmaceuticals Inc Annual Diluted Shares Outstanding for 2016 was $8m a 31.24% increase of 3m from 2015
Other Per Share Metrics:
  • Apellis Pharmaceuticals Inc Diluted EPS Excl. Extra Items for the quarter ending December 12, 2018 was $-1m a 33.37% decrease of 0m year over year
  • Apellis Pharmaceuticals Inc Diluted EPS Incl. Extra Items for the quarter ending December 12, 2018 was $-1m a 33.37% decrease of 0m year over year
View Chart On Koyfin

Quarterly APLS Diluted Shares Outstanding Data

12/2018$56m
09/2018$56m
06/2018$55m
03/2018$50m
12/2017$30m
09/2017$8m
06/2017$8m

Annual APLS Diluted Shares Outstanding Data

2018$54m
2017$14m
2016$8m
2015$6m